As the healthcare industry becomes more connected, securing medical devices is no longer optional—it’s essential. Systems and devices that handle sensitive patient data are now being required to meet strict security standards. Evaluating protection of sensitive data within products will no longer be a differentiator, it will be a barrier to entry.

A New Way of Supporting Patient Health

Innovation in connectivity has not stopped at consumer technology; it has become deeply embedded in the medical field through advanced equipment and devices. Modern hospitals and clinics now rely on interconnected medical technologies such as infusion pumps, ventilators, imaging systems, and wearable monitors, all designed to share data seamlessly across networks. These devices enable healthcare providers to track patient conditions in real time, improve diagnostic accuracy, and deliver faster, more personalized treatment. The benefits are undeniable: increased efficiency, improved outcomes, and more accessible care. Yet, this growing reliance on networked medical devices also introduces significant risks. A single vulnerability in a connected device can open the door to cyberattacks, leading to data breaches, exposure of patient records, or even the manipulation of life-sustaining equipment. Protecting these devices is therefore not only a matter of securing information but of safeguarding patient safety and trust. As medical technology continues to advance, the demand for robust cybersecurity measures tailored specifically to medical equipment has never been more urgent.

The Challenge Ahead

Medical device companies operate in one of the most tightly regulated industries in the world—and the path becomes even more difficult when targeting the U.S. federal government as a customer. While the opportunity can be lucrative, gaining access to this market comes with a unique set of challenges that can quickly become overwhelming without a clear strategy. To succeed, companies must prove not only that their products are safe and effective, but also that they meet stringent regulatory and cybersecurity requirements. They must navigate a landscape shaped by evolving federal mandates, rigorous compliance expectations, and complex procurement processes that can extend sales cycles for months or even years.  

For medical device manufacturers looking to expand into the U.S. federal market, these are just a few of the major hurdles: 

1. Constantly Changing Global and Federal Regulations
   The regulatory environment is in constant flux. Agencies such as the FDA, Department of Defense, and Department of Veterans Affairs regularly update their standards to reflect new technologies, threats, and political priorities. Staying compliant means staying informed—and often requires reworking product features, documentation, or security architectures just to remain eligible for federal contracts.
2. Extensive Documentation and Testing Requirements
   Entering the federal market isn’t just about having a functional product. Companies must invest in rigorous testing protocols and produce detailed documentation that proves product safety, performance, and interoperability. This includes everything from clinical validation studies to cybersecurity posture assessments. One overlooked requirement can delay approvals by months or disqualify a bid entirely.
   
3. Long Sales Cycles and Strict Contracting Rules
   Selling to the government is nothing like selling to the private sector. The process is often protracted and layered with approvals, vendor registrations, procurement vehicles, and compliance checks. Understanding how to navigate FAR (Federal Acquisition Regulations), secure a place on approved contract vehicles like GSA Schedules, or build relationships with system integrators is essential—but time-consuming.
4. Security and Compliance Demands
   Beyond FDA approval, federal buyers demand proof that devices meet the highest security standards. Frameworks like FIPS 140-3 for cryptographic modules, HIPAA for patient data privacy, and other NIST-based requirements are table stakes for participation. Meeting these standards often requires significant re-architecture of systems and undergoing third-party validations—especially for products that store, transmit, or process sensitive information.
5. High Costs Tied to Engineering, Marketing, and Monitoring
   All of these challenges translate into substantial upfront and ongoing investment. Whether it’s hiring compliance consultants, modifying product designs, or building custom sales materials for federal buyers, the costs can mount quickly. And even post-sale, companies are expected to monitor system performance, report vulnerabilities, and ensure continued compliance—driving long-term resource commitments. 

Supporting Industry Requirements Through Validation

The good news is that proven steps and processes exist to strengthen this protection. One of the most effective is the use of FIPS 140-3 validated products, which provide a recognized standard for cryptographic security. For medical device manufacturers, implementing FIPS 140-3 validation offers a strategic advantage: it ensures the data collected and transmitted by devices is safeguarded against compromise, while also reducing concerns about device integrity. Certification builds trust not only with patients, but also with healthcare providers, regulators such as the FDA, and organizations that deploy these solutions—including federal agencies like the Department of Veterans Affairs and large hospital systems. In a competitive market, achieving FIPS 140-3 validation helps products stand out, especially for critical devices such as heart monitors, pacemakers, and infusion pumps where patient safety and data security are paramount. By aligning innovation with certified security, medical device manufacturers can both differentiate their products and reassure stakeholders that safety has been built into the core of their technology.

What is FIPS 140-3?

FIPS 140-3 validation ensures that cryptographic modules meet rigorous standards for encryption, key management, authentication, and tamper resistance. This includes protections against common attack vectors such as side-channel attacks, brute-force decryption, and unauthorized firmware updates. Devices validated under this standard demonstrate strong resistance to both software-based and physical attacks, making them resilient in the face of evolving cyber threats. For manufacturers, adopting FIPS 140-3 validated cryptographic modules not only streamlines compliance with federal and healthcare regulations, but also provides a scalable foundation for securing future device generations.

In short, this certification is more than a regulatory checkbox—it is a technical safeguard that strengthens the integrity, reliability, and trustworthiness of modern medical devices.

The Corsec Advantage

As a privately owned company with over 27 years of experience, Corsec has partnered with organizations worldwide to deliver comprehensive security certification solutions. Having guided medical device companies and technology vendors through more than 500 successful certifications—including FIPS 140, Common Criteria, CSfC, and DoD STIGs —Corsec offers unmatched expertise in navigating complex certification landscapes. From early design reviews to lab coordination and final approval, our proven process streamlines every step, mitigating delays and avoiding costly pitfalls. With experience securing products across diverse industries, from storage devices to satellites, Corsec provides the knowledge and hands-on support manufacturers need to bring FIPS 140-3 validated medical devices to market quickly and confidently.

By partnering with Corsec, medical device companies gain not just a guide through certification, but a trusted ally in building secure, compliant, and market-ready solutions.

Ready to Get Started?

Let Corsec help you bring secure, certified products to the market faster. Learn more about our FIPS services → https://www.corsec.com/fips-140-3/